François Rousseau
- Formation
- à venir
Aucune offre active
Autres opportunités de carrièreAucune étude clinique active
Autres études cliniques
- Axe principal
- Transfert des connaissances et évaluation des technologies et des modes d'intervention en santé
- Adresse
- 10, rue de l'Espinay, A2-222
Québec (Québec)
CANADA G1L 3L5 - Téléphone
- +1 418-525-4470
- Télécopieur
- +1 418-525-4195
- Courriel
- francois.rousseau@crsfa.chuq.qc.ca
Publications récentes (voir toutes les publications de ce chercheur)
Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Legare F, Forest JC. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clinical chemistry,
2010. 56: 361-75
Levesque S, Dombrowski C, Morel ML, Rehel R, Cote JS, Bussieres J, Morgan K, Rousseau F. Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population. Clinical genetics,
2009. Epub
Ghadirian P, Robidoux A, Zhang P, Royer R, Akbari M, Zhang S, Fafard E, Costa M, Martin G, Potvin C, Patocskai E, Larouche N, Younan R, Nassif E, Giroux S, Narod SA, Rousseau F, Foulkes WD. The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Clinical genetics,
2009. 76: 421-6
Elfassihi L, Giroux S, Bureau A, Laflamme N, Cole DE, Rousseau F. Association With Replication Between Estrogen-Related Receptor Gamma (ESRRG) Polymorphisms and Bone Phenotypes in Women of European Ancestry. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
2009. Epub
Gekas J, Gagne G, Bujold E, Douillard D, Forest JC, Reinharz D, Rousseau F. Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation. BMJ (Clinical research ed.),
2009. 338: b138
Rousseau F, Gancberg D, Schimmel H, Neumaier M, Bureau A, Mamotte C, van Schaik R, Payne D, Pazzagli M, Young I. Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory Medicine. Clinical chemistry and laboratory medicine : CCLM / FESCC,
2009. 47: 1343-50
Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, Giguere Y, Berube S, Brisson J. Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocrine-related cancer,
2008. 15: 975-83
van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellstrom D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG, GENOMOS Study. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA : the journal of the American Medical Association,
2008. 299: 1277-90
Zhang S, Phelan CM, Zhang P, Rousseau F, Ghadirian P, Robidoux A, Foulkes W, Hamel N, McCready D, Trudeau M, Lynch H, Horsman D, De Matsuda ML, Aziz Z, Gomes M, Costa MM, Liede A, Poll A, Sun P, Narod SA. Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. Cancer research,
2008. 68: 2154-7
Novak DJ, Chen LQ, Ghadirian P, Hamel N, Zhang P, Rossiny V, Cardinal G, Robidoux A, Tonin PN, Rousseau F, Narod SA, Foulkes WD. Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women. BMC cancer,
2008. 8: 239
